IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma
Jacob S. Young, Nam Woo Cho, Calixto‐Hope G. Lucas, Hinda Najem, Kanish Mirchia, William C. Chen, Courtney M. Tamaki, Harrshavasan Congivaram, Kyounghee Seo, Naomi Zakimi, Vikas Daggubati, Tim Casey-Clyde, Minh P. Nguyen, Zhenhong Chen, Joanna J. Phillips, , David Ronan Raleigh
This study identifies IL-6 as a driver of immunosuppression in glioblastoma, showing that its inhibition enhances response to immune checkpoint therapy and radiotherapy in preclinical models.
Cancer Research · Apr 13, 2026Peer-reviewedCancer Biology